Cargando…

Totally thoracoscopic surgery for treating left atrial myxoma

We aimed to summarize the experience of totally thoracoscopic surgery for left atrial myxoma, together with analyzing the safety and feasibility. We retrospectively analyzed the clinical data of 15 patients with left atrial myxoma admitted to our hospital from October 2016 to October 2018. The auxil...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Feng, Chen, Tongyun, Tang, Yipeng, Chen, Qingliang, Jiang, Nan, Guo, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589240/
https://www.ncbi.nlm.nih.gov/pubmed/34766596
http://dx.doi.org/10.1097/MD.0000000000027819
_version_ 1784598658115698688
author Zhao, Feng
Chen, Tongyun
Tang, Yipeng
Chen, Qingliang
Jiang, Nan
Guo, Zhigang
author_facet Zhao, Feng
Chen, Tongyun
Tang, Yipeng
Chen, Qingliang
Jiang, Nan
Guo, Zhigang
author_sort Zhao, Feng
collection PubMed
description We aimed to summarize the experience of totally thoracoscopic surgery for left atrial myxoma, together with analyzing the safety and feasibility. We retrospectively analyzed the clinical data of 15 patients with left atrial myxoma admitted to our hospital from October 2016 to October 2018. The auxiliary hole was located at the midline of the 5th intercostal space of the right chest. The endoscope hole was located at the front position of the fourth intercostal space. Specimens were sent to the pathology department for pathological examination. All the procedures were completed successfully. Extracorporeal circulation time was 46.5 ± 18.6 minute, cross-clamping time was 20.6 ± 6.7 minute, thoracic drainage fluid was 89+60.2 ml, ventilator assist time was 4.3 ± 2.6 hour, intensive care unit stay time was 14.5 ± 4.2 hour, the average postoperative hospital stay was 5.2 ± 1.2 day. There was no death, or red blood cell transfusion during and after surgery. No postoperative complications were reported by the patients. No recurrence of myxoma, residual shunt in the atrial septum and valvular lesions were found after 3months of postoperative cardiac ultrasound examination. Total thoracoscopic surgery for left atrial myxoma was less invasive with satisfactory cosmetic appearance with feasibility and safety. Besides, it caused no serious complications.
format Online
Article
Text
id pubmed-8589240
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85892402021-11-15 Totally thoracoscopic surgery for treating left atrial myxoma Zhao, Feng Chen, Tongyun Tang, Yipeng Chen, Qingliang Jiang, Nan Guo, Zhigang Medicine (Baltimore) 6600 We aimed to summarize the experience of totally thoracoscopic surgery for left atrial myxoma, together with analyzing the safety and feasibility. We retrospectively analyzed the clinical data of 15 patients with left atrial myxoma admitted to our hospital from October 2016 to October 2018. The auxiliary hole was located at the midline of the 5th intercostal space of the right chest. The endoscope hole was located at the front position of the fourth intercostal space. Specimens were sent to the pathology department for pathological examination. All the procedures were completed successfully. Extracorporeal circulation time was 46.5 ± 18.6 minute, cross-clamping time was 20.6 ± 6.7 minute, thoracic drainage fluid was 89+60.2 ml, ventilator assist time was 4.3 ± 2.6 hour, intensive care unit stay time was 14.5 ± 4.2 hour, the average postoperative hospital stay was 5.2 ± 1.2 day. There was no death, or red blood cell transfusion during and after surgery. No postoperative complications were reported by the patients. No recurrence of myxoma, residual shunt in the atrial septum and valvular lesions were found after 3months of postoperative cardiac ultrasound examination. Total thoracoscopic surgery for left atrial myxoma was less invasive with satisfactory cosmetic appearance with feasibility and safety. Besides, it caused no serious complications. Lippincott Williams & Wilkins 2021-11-12 /pmc/articles/PMC8589240/ /pubmed/34766596 http://dx.doi.org/10.1097/MD.0000000000027819 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6600
Zhao, Feng
Chen, Tongyun
Tang, Yipeng
Chen, Qingliang
Jiang, Nan
Guo, Zhigang
Totally thoracoscopic surgery for treating left atrial myxoma
title Totally thoracoscopic surgery for treating left atrial myxoma
title_full Totally thoracoscopic surgery for treating left atrial myxoma
title_fullStr Totally thoracoscopic surgery for treating left atrial myxoma
title_full_unstemmed Totally thoracoscopic surgery for treating left atrial myxoma
title_short Totally thoracoscopic surgery for treating left atrial myxoma
title_sort totally thoracoscopic surgery for treating left atrial myxoma
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589240/
https://www.ncbi.nlm.nih.gov/pubmed/34766596
http://dx.doi.org/10.1097/MD.0000000000027819
work_keys_str_mv AT zhaofeng totallythoracoscopicsurgeryfortreatingleftatrialmyxoma
AT chentongyun totallythoracoscopicsurgeryfortreatingleftatrialmyxoma
AT tangyipeng totallythoracoscopicsurgeryfortreatingleftatrialmyxoma
AT chenqingliang totallythoracoscopicsurgeryfortreatingleftatrialmyxoma
AT jiangnan totallythoracoscopicsurgeryfortreatingleftatrialmyxoma
AT guozhigang totallythoracoscopicsurgeryfortreatingleftatrialmyxoma